M Zaigler - Concepedia

Author

M Zaigler

University of Cologne

Also Known As

M ZAIGLER, M Zaigler, M. Zaigler

Publications

472

Citations

H-Index

Concepts

All Affiliations

University of Cologne

About

M Zaigler is an author at University of Cologne specializing in medicine, pharmacotherapy, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	254
2	Pharmacology	2	2	254
3	Health Sciences	1	1	182
4	Metabolism	1	1	182
5	Clinical Pharmacology	1	1	182

M Zaigler

Publications

430

Citations

H-Index

Page 1

	Year	Citations
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. I. Tantcheva‐Poór, M Zaigler, Stephan Rietbrock, PubMed PharmacotherapyHealthy CaucasiansPhysiologically-based Pharmacokinetic ModelingMolecular PharmacologyTobacco Control	1999	182
Grapefruit juice increases oral nimodipine bioavailability. Uwe Fuhr, A Maier-Brüggemann, Henning Blume, PubMed Drug InteractionsPharmacological StudyGrapefruit Juice IntakePhysiologyPharmacology	1998	72
Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes M. Baumhäkel, Dirk Kasel, Rose Rao‐Schymanski, International Journal of Clinical Pharmacology and Therapeutics	2001	47
Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2 M. Kinzig‐Schippers, Uwe Fuhr, M Zaigler, Clinical Pharmacology & Therapeutics	1999	39
Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women M Zaigler, Stephan Rietbrock, Jędrzej Szymański, International Journal of Clinical Pharmacology and Therapeutics	2000	35
Absorption pattern of trospium chloride along the human gastrointestinal tract assessed using local enteral administration Sven Schröder, Alexander Jetter, M Zaigler, International Journal of Clinical Pharmacology and Therapeutics	2004	20
Rate-limiting biotransformation of triamterene is mediated by CYP1A2 Uwe Fuhr, S. Kober, M Zaigler, International Journal of Clinical Pharmacology and Therapeutics	2005	19
Omeprazole weakly inhibits CYP1A2 activity in man. Karl Ludwig Rost, Uwe Fuhr, T. Thomsen, PubMed	1999	16

Page 1